My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Fingolimod Bluefish 0.5 mg hard capsules



Bluefish Pharmaceuticals ABPA1436/035/001

Main Information

Trade NameFingolimod Bluefish 0.5 mg hard capsules
Active SubstancesFINGOLIMOD HYDROCHLORIDE
Dosage FormCapsule, hard
Licence HolderBluefish Pharmaceuticals AB
Licence NumberPA1436/035/001

Group Information

ATC CodeL04AA27 fingolimod

Status

License statusAuthorised
Licence Issued25/03/2022
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print